FDA Import Refusal 799-3949418-2/11/1 — Hetero Labs Ltd. Unit VI
The FDA refused shipment 799-3949418-2/11/1 from Hetero Labs Ltd. Unit VI (India) on August 12, 2021. The refused product falls under Drugs and Biologics — LETROZOLE (ANTI-NEOPLASTIC). Cited charge: 75 This firm has 3 other import refusals on record.
Refusal Details
- Date
- August 12, 2021
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62ICB85 LETROZOLE (ANTI-NEOPLASTIC)
- Charges
- 75